Targeted Chemo for Breast Cancer
It might not seem like good news. A paper in this week's New England Journal of Medicine shows that one of the most common breast cancer chemotherapy drugs doesn't work for probably half the women taking it.
Join the discussion below, or Read more at Time.
#1 Jan 14, 2013
Paclitaxel and Abraxane therapy has been shown to not be given to "patients with metastatic breast cancer who have baseline neutrophil counts of less than 1,500 cells/mm3." This is because of neutropenia and possibility of infection.
Add your comments below
|Biden Hosting Cancer Summit to Try to Accelerat...||Jun '16||Unsolicited Advice||2|
|Biden hosting cancer summit to try to accelerat...||Jun '16||Le Jimbo||1|
|Racially biased cancer doctors spend less time ...||Jun '16||Summer Friend||6|
|Thoughts on new CMS rules for billing on ambula...||Jun '16||Novice||1|
|Long-term outcomes in radically treated synchro...||Jun '16||why use BIG words||1|
|Screening for breast and cervical cancer is a p...||May '16||Three Days 5K||1|
|Not just pets: Dogs, cats may show way to bette...||May '16||Dumb Animals||2|
Find what you want!
Search Oncology Forum Now
Copyright © 2016 Topix LLC